APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propranolol

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Propranolol Industry Growth and Trends Forecast to 2032

28 December 2025117 pages

Choose your research edition.

Industry ResearchPropranolol Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Propranolol Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Propranolol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propranolol Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Propranolol Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Propranolol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Propranolol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Propranolol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propranolol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Propranolol include Yabang Pharma, Teva, Sanofi, Novartis, Mylan, AstraZeneca, Zydus Pharma, Zentiva and Towa Yakuhin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Propranolol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Propranolol market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Propranolol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Propranolol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Propranolol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Propranolol Market by Company

Yabang Pharma

Teva

Sanofi

Novartis

Mylan

AstraZeneca

Zydus Pharma

Zentiva

Towa Yakuhin

Sawai Seiyaku

Nichi-Iko Pharmaceutical

Iqfarma

Intas Pharma

IFET

Atnas Pharma

Apotex

ABZ-Pharma

Propranolol Segment by Type

Oral

Injection

Propranolol Segment by Application

Arrhythmia

Hypertension

Others

Propranolol Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propranolol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propranolol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propranolol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Propranolol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Propranolol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Propranolol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Propranolol Sales by Type (2021-2026) & (K Units) Table 5. Global Propranolol Sales Market Share in Volume by Type (2021-2026) Table 6. Global Propranolol Sales by Type (2021-2026) & (US$ Million) Table 7. Global Propranolol Sales Market Share in Value by Type (2021-2026) Table 8. Global Propranolol Price by Type (2021-2026) & (US$/Unit) Table 9. Global Propranolol Sales by Type (2027-2032) & (K Units) Table 10. Global Propranolol Sales Market Share in Volume by Type (2027-2032) Table 11. Global Propranolol Sales by Type (2027-2032) & (US$ Million) Table 12. Global Propranolol Sales Market Share in Value by Type (2027-2032) Table 13. Global Propranolol Price by Type (2027-2032) & (US$/Unit) Table 14. North America Propranolol Sales by Type (2021-2026) & (K Units) Table 15. North America Propranolol Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Propranolol Sales by Type (2021-2026) & (K Units) Table 17. Europe Propranolol Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Propranolol Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Propranolol Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Propranolol Sales by Type (2021-2026) & (K Units) Table 21. Latin America Propranolol Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Propranolol Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Propranolol Sales by Type (2021-2026) & (US$ Million) Table 24. Propranolol Industry Trends Table 25. Propranolol Industry Drivers Table 26. Propranolol Industry Opportunities and Challenges Table 27. Propranolol Industry Restraints Table 28. Global Propranolol Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Propranolol Revenue Market Share by Company (2021-2026) Table 30. Global Propranolol Sales by Company (2021-2026) & (K Units) Table 31. Global Propranolol Sales Share by Company (2021-2026) Table 32. Global Propranolol Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Propranolol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Propranolol Major Company Production Sites and Headquarters Table 35. Global Propranolol Company, Product Type & Application Table 36. Global Propranolol Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Propranolol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Propranolol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Propranolol Sales by Region (2021-2026) & (K Units) Table 41. Global Propranolol Sales Market Share in Volume by Region (2021-2026) Table 42. Global Propranolol Sales by Region (2021-2026) & (US$ Million) Table 43. Global Propranolol Sales Market Share in Value by Region (2021-2026) Table 44. Global Propranolol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Propranolol Sales by Region (2027-2032) & (K Units) Table 46. Global Propranolol Sales Market Share in Volume by Region (2027-2032) Table 47. Global Propranolol Sales by Region (2027-2032) & (US$ Million) Table 48. Global Propranolol Sales Market Share in Value by Region (2027-2032) Table 49. Global Propranolol Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Propranolol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Propranolol Sales by Application (2021-2026) & (K Units) Table 52. Global Propranolol Sales Market Share in Volume by Application (2021-2026) Table 53. Global Propranolol Sales by Application (2021-2026) & (US$ Million) Table 54. Global Propranolol Sales Market Share in Value by Application (2021-2026) Table 55. Global Propranolol Price by Application (2021-2026) & (US$/Unit) Table 56. Global Propranolol Sales by Application (2027-2032) & (K Units) Table 57. Global Propranolol Sales Market Share in Volume by Application (2027-2032) Table 58. Global Propranolol Sales by Application (2027-2032) & (US$ Million) Table 59. Global Propranolol Sales Market Share in Value by Application (2027-2032) Table 60. Global Propranolol Price by Application (2027-2032) & (US$/Unit) Table 61. North America Propranolol Sales by Application (2021-2026) & (K Units) Table 62. North America Propranolol Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Propranolol Sales by Application (2021-2026) & (K Units) Table 64. Europe Propranolol Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Propranolol Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Propranolol Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Propranolol Sales by Application (2021-2026) & (K Units) Table 68. Latin America Propranolol Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Propranolol Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Propranolol Sales by Application (2021-2026) & (US$ Million) Table 71. Yabang Pharma Company Information Table 72. Yabang Pharma Business Overview Table 73. Yabang Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Yabang Pharma Propranolol Product Portfolio Table 75. Yabang Pharma Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Teva Propranolol Product Portfolio Table 80. Teva Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sanofi Propranolol Product Portfolio Table 85. Sanofi Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novartis Propranolol Product Portfolio Table 90. Novartis Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Mylan Propranolol Product Portfolio Table 95. Mylan Recent Development Table 96. AstraZeneca Company Information Table 97. AstraZeneca Business Overview Table 98. AstraZeneca Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. AstraZeneca Propranolol Product Portfolio Table 100. AstraZeneca Recent Development Table 101. Zydus Pharma Company Information Table 102. Zydus Pharma Business Overview Table 103. Zydus Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Zydus Pharma Propranolol Product Portfolio Table 105. Zydus Pharma Recent Development Table 106. Zentiva Company Information Table 107. Zentiva Business Overview Table 108. Zentiva Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zentiva Propranolol Product Portfolio Table 110. Zentiva Recent Development Table 111. Towa Yakuhin Company Information Table 112. Towa Yakuhin Business Overview Table 113. Towa Yakuhin Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Towa Yakuhin Propranolol Product Portfolio Table 115. Towa Yakuhin Recent Development Table 116. Sawai Seiyaku Company Information Table 117. Sawai Seiyaku Business Overview Table 118. Sawai Seiyaku Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sawai Seiyaku Propranolol Product Portfolio Table 120. Sawai Seiyaku Recent Development Table 121. Nichi-Iko Pharmaceutical Company Information Table 122. Nichi-Iko Pharmaceutical Business Overview Table 123. Nichi-Iko Pharmaceutical Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Nichi-Iko Pharmaceutical Propranolol Product Portfolio Table 125. Nichi-Iko Pharmaceutical Recent Development Table 126. Iqfarma Company Information Table 127. Iqfarma Business Overview Table 128. Iqfarma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Iqfarma Propranolol Product Portfolio Table 130. Iqfarma Recent Development Table 131. Intas Pharma Company Information Table 132. Intas Pharma Business Overview Table 133. Intas Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Intas Pharma Propranolol Product Portfolio Table 135. Intas Pharma Recent Development Table 136. IFET Company Information Table 137. IFET Business Overview Table 138. IFET Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. IFET Propranolol Product Portfolio Table 140. IFET Recent Development Table 141. Atnas Pharma Company Information Table 142. Atnas Pharma Business Overview Table 143. Atnas Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Atnas Pharma Propranolol Product Portfolio Table 145. Atnas Pharma Recent Development Table 146. Apotex Company Information Table 147. Apotex Business Overview Table 148. Apotex Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Apotex Propranolol Product Portfolio Table 150. Apotex Recent Development Table 151. ABZ-Pharma Company Information Table 152. ABZ-Pharma Business Overview Table 153. ABZ-Pharma Propranolol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. ABZ-Pharma Propranolol Product Portfolio Table 155. ABZ-Pharma Recent Development Table 156. North America Propranolol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Propranolol Sales by Country (2021-2026) & (K Units) Table 158. North America Propranolol Sales Market Share by Country (2021-2026) Table 159. North America Propranolol Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Propranolol Sales Market Share Forecast by Country (2027-2032) Table 161. North America Propranolol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Propranolol Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Propranolol Market Share by Country (2021-2026) Table 164. North America Propranolol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Propranolol Market Share Forecast by Country (2027-2032) Table 166. Europe Propranolol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Propranolol Sales by Country (2021-2026) & (K Units) Table 168. Europe Propranolol Sales Market Share by Country (2021-2026) Table 169. Europe Propranolol Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Propranolol Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Propranolol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Propranolol Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Propranolol Market Share by Country (2021-2026) Table 174. Europe Propranolol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Propranolol Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Propranolol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Propranolol Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Propranolol Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Propranolol Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Propranolol Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Propranolol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Propranolol Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Propranolol Market Share by Country (2021-2026) Table 184. Asia-Pacific Propranolol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Propranolol Market Share Forecast by Country (2027-2032) Table 186. Latin America Propranolol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Propranolol Sales by Country (2021-2026) & (K Units) Table 188. Latin America Propranolol Sales Market Share by Country (2021-2026) Table 189. Latin America Propranolol Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Propranolol Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Propranolol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Propranolol Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Propranolol Market Share by Country (2021-2026) Table 194. Latin America Propranolol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Propranolol Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Propranolol Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Propranolol Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Propranolol Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Propranolol Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Propranolol Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Propranolol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Propranolol Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Propranolol Market Share by Country (2021-2026) Table 204. Middle East and Africa Propranolol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Propranolol Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Propranolol Distributors List Table 209. Propranolol Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Propranolol Image Figure 2. Global Propranolol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propranolol Market Size (2021-2032) & (US$ Million) Figure 4. Global Propranolol Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Propranolol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Propranolol Market Share by Type 2025 VS 2032 Figure 11. North America Propranolol Sales Market Share in Volume by Type in 2025 Figure 12. North America Propranolol Sales Market Share in Value by Type in 2025 Figure 13. Europe Propranolol Sales Market Share in Volume by Type in 2025 Figure 14. Europe Propranolol Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Propranolol Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Propranolol Sales Market Share in Value by Type in 2025 Figure 17. Latin America Propranolol Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Propranolol Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Propranolol Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Propranolol Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Propranolol Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Arrhythmia Image Figure 24. Global Arrhythmia Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hypertension Image Figure 26. Global Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Propranolol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Propranolol Market Share by Application 2025 VS 2032 Figure 31. North America Propranolol Sales Market Share in Volume by Application in 2025 Figure 32. North America Propranolol Sales Market Share in Value by Application in 2025 Figure 33. Europe Propranolol Sales Market Share in Volume by Application in 2025 Figure 34. Europe Propranolol Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Propranolol Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Propranolol Sales Market Share in Value by Application in 2025 Figure 37. Latin America Propranolol Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Propranolol Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Propranolol Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Propranolol Sales Market Share in Value by Application in 2025 Figure 41. North America Propranolol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Propranolol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Propranolol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Propranolol Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Propranolol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Propranolol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Propranolol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Propranolol Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Propranolol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Propranolol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Propranolol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Propranolol Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Propranolol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Propranolol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Propranolol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Propranolol Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Propranolol Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Propranolol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Propranolol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Propranolol Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Propranolol Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Propranolol Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Arrhythmia
  • Hypertension
  • Others
Companies covered
  • Yabang Pharma
  • Teva
  • Sanofi
  • Novartis
  • Mylan
  • AstraZeneca
  • Zydus Pharma
  • Zentiva
  • Towa Yakuhin
  • Sawai Seiyaku
  • Nichi-Iko Pharmaceutical
  • Iqfarma
  • Intas Pharma
  • IFET
  • Atnas Pharma
  • Apotex
  • ABZ-Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propranolol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Propranolol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Propranolol Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Propranolol Market Size by Type
  9. 1.4.1 Global Propranolol Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Propranolol Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Propranolol Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Propranolol Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Propranolol Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Propranolol Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Propranolol Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Propranolol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Propranolol Industry Trends
  2. 2.2 Propranolol Industry Drivers
  3. 2.3 Propranolol Industry Opportunities and Challenges
  4. 2.4 Propranolol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Propranolol Revenue (2021-2026)
  2. 3.2 Global Top Players by Propranolol Sales (2021-2026)
  3. 3.3 Global Top Players by Propranolol Price (2021-2026)
  4. 3.4 Global Propranolol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Propranolol Major Company Production Sites & Headquarters
  6. 3.6 Global Propranolol Company, Product Type & Application
  7. 3.7 Global Propranolol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Propranolol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Propranolol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Propranolol Tier 1, Tier 2, and Tier 3
4 Propranolol Regional Status and Outlook
  1. 4.1 Global Propranolol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Propranolol Historic Market Size by Region
  3. 4.2.1 Global Propranolol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Propranolol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Propranolol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Propranolol Forecasted Market Size by Region
  7. 4.3.1 Global Propranolol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Propranolol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Propranolol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Propranolol by Application
  1. 5.1 Propranolol Market by Application
  2. 5.1.1 Arrhythmia
  3. 5.1.2 Hypertension
  4. 5.1.3 Others
  5. 5.2 Global Propranolol Market Size by Application
  6. 5.2.1 Global Propranolol Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Propranolol Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Propranolol Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Propranolol Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Propranolol Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Propranolol Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Propranolol Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Propranolol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yabang Pharma
  2. 6.1.1 Yabang Pharma Company Information
  3. 6.1.2 Yabang Pharma Business Overview
  4. 6.1.3 Yabang Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yabang Pharma Propranolol Product Portfolio
  6. 6.1.5 Yabang Pharma Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Propranolol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Propranolol Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Propranolol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Propranolol Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Propranolol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Propranolol Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Propranolol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Propranolol Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 AstraZeneca
  32. 6.6.1 AstraZeneca Company Information
  33. 6.6.2 AstraZeneca Business Overview
  34. 6.6.3 AstraZeneca Propranolol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AstraZeneca Propranolol Product Portfolio
  36. 6.6.5 AstraZeneca Recent Developments
  37. 6.7 Zydus Pharma
  38. 6.7.1 Zydus Pharma Company Information
  39. 6.7.2 Zydus Pharma Business Overview
  40. 6.7.3 Zydus Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zydus Pharma Propranolol Product Portfolio
  42. 6.7.5 Zydus Pharma Recent Developments
  43. 6.8 Zentiva
  44. 6.8.1 Zentiva Company Information
  45. 6.8.2 Zentiva Business Overview
  46. 6.8.3 Zentiva Propranolol Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zentiva Propranolol Product Portfolio
  48. 6.8.5 Zentiva Recent Developments
  49. 6.9 Towa Yakuhin
  50. 6.9.1 Towa Yakuhin Company Information
  51. 6.9.2 Towa Yakuhin Business Overview
  52. 6.9.3 Towa Yakuhin Propranolol Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Towa Yakuhin Propranolol Product Portfolio
  54. 6.9.5 Towa Yakuhin Recent Developments
  55. 6.10 Sawai Seiyaku
  56. 6.10.1 Sawai Seiyaku Company Information
  57. 6.10.2 Sawai Seiyaku Business Overview
  58. 6.10.3 Sawai Seiyaku Propranolol Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sawai Seiyaku Propranolol Product Portfolio
  60. 6.10.5 Sawai Seiyaku Recent Developments
  61. 6.11 Nichi-Iko Pharmaceutical
  62. 6.11.1 Nichi-Iko Pharmaceutical Company Information
  63. 6.11.2 Nichi-Iko Pharmaceutical Business Overview
  64. 6.11.3 Nichi-Iko Pharmaceutical Propranolol Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nichi-Iko Pharmaceutical Propranolol Product Portfolio
  66. 6.11.5 Nichi-Iko Pharmaceutical Recent Developments
  67. 6.12 Iqfarma
  68. 6.12.1 Iqfarma Company Information
  69. 6.12.2 Iqfarma Business Overview
  70. 6.12.3 Iqfarma Propranolol Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Iqfarma Propranolol Product Portfolio
  72. 6.12.5 Iqfarma Recent Developments
  73. 6.13 Intas Pharma
  74. 6.13.1 Intas Pharma Company Information
  75. 6.13.2 Intas Pharma Business Overview
  76. 6.13.3 Intas Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Intas Pharma Propranolol Product Portfolio
  78. 6.13.5 Intas Pharma Recent Developments
  79. 6.14 IFET
  80. 6.14.1 IFET Company Information
  81. 6.14.2 IFET Business Overview
  82. 6.14.3 IFET Propranolol Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 IFET Propranolol Product Portfolio
  84. 6.14.5 IFET Recent Developments
  85. 6.15 Atnas Pharma
  86. 6.15.1 Atnas Pharma Company Information
  87. 6.15.2 Atnas Pharma Business Overview
  88. 6.15.3 Atnas Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Atnas Pharma Propranolol Product Portfolio
  90. 6.15.5 Atnas Pharma Recent Developments
  91. 6.16 Apotex
  92. 6.16.1 Apotex Company Information
  93. 6.16.2 Apotex Business Overview
  94. 6.16.3 Apotex Propranolol Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Apotex Propranolol Product Portfolio
  96. 6.16.5 Apotex Recent Developments
  97. 6.17 ABZ-Pharma
  98. 6.17.1 ABZ-Pharma Company Information
  99. 6.17.2 ABZ-Pharma Business Overview
  100. 6.17.3 ABZ-Pharma Propranolol Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 ABZ-Pharma Propranolol Product Portfolio
  102. 6.17.5 ABZ-Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Propranolol Sales by Country
  2. 7.1.1 North America Propranolol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Propranolol Sales by Country (2021-2026)
  4. 7.1.3 North America Propranolol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Propranolol Market Size by Country
  6. 7.2.1 North America Propranolol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Propranolol Market Size by Country (2021-2026)
  8. 7.2.3 North America Propranolol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Propranolol Sales by Country
  2. 8.1.1 Europe Propranolol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Propranolol Sales by Country (2021-2026)
  4. 8.1.3 Europe Propranolol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Propranolol Market Size by Country
  6. 8.2.1 Europe Propranolol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Propranolol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Propranolol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Propranolol Sales by Country
  2. 9.1.1 Asia-Pacific Propranolol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Propranolol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Propranolol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Propranolol Market Size by Country
  6. 9.2.1 Asia-Pacific Propranolol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Propranolol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Propranolol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Propranolol Sales by Country
  2. 10.1.1 South America Propranolol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Propranolol Sales by Country (2021-2026)
  4. 10.1.3 South America Propranolol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Propranolol Market Size by Country
  6. 10.2.1 South America Propranolol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Propranolol Market Size by Country (2021-2026)
  8. 10.2.3 South America Propranolol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Propranolol Sales by Country
  2. 11.1.1 Middle East and Africa Propranolol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Propranolol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Propranolol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Propranolol Market Size by Country
  6. 11.2.1 Middle East and Africa Propranolol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Propranolol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Propranolol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Propranolol Value Chain Analysis
  2. 12.1.1 Propranolol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Propranolol Production Mode & Process
  7. 12.2 Propranolol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Propranolol Distributors
  10. 12.2.3 Propranolol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst